Blog

Driving cancer beyond the brink – Chemical & Engineering News


Chemical & Engineering News

Driving cancer beyond the brink
Chemical & Engineering News
Newfound excitement about the century-old idea is fueled by real-world experience with PARP inhibitors, which are the first class of drugs to work by the mechanism, and by the potential for companies to use the powerful gene-editing tool CRISPR to find

2017-10-09 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.